Ibuprofene Eg Conseil

Ibuprofen, the active ingredient in Ibuprofene Eg Conseil, is a Non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is used to relieve pain, reduce fever, and diminish inflammation in adults and children when appropriate.

GNH USA supplies Ibuprofene Eg Conseil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts as an analgesic, antipyretic and anti‑inflammatory agent across several common conditions. - Pain: provides relief of mild to moderate pain such as headache, dental pain, or musculoskeletal discomfort. - Fever: lowers elevated body temperature associated with infections or inflammatory states. - Inflammation: reduces swelling and redness in conditions like sprains, strains, and soft‑tissue injuries. - Arthritis: helps control pain and stiffness in osteoarthritis and rheumatoid arthritis.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated blood pressure in susceptible individuals.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment or acute kidney injury. - Severe hypersensitivity reactions, including anaphylaxis. - Hepatotoxicity presenting as jaundice or elevated liver enzymes. - Cardiovascular events such as myocardial infarction or stroke, particularly with high‑dose or prolonged use.

Before initiating ibuprofen therapy, consider the following safety measures. - Assess renal function: avoid use in patients with severe renal insufficiency. - Evaluate cardiovascular risk: use the lowest effective dose for the shortest duration. - Review gastrointestinal history: avoid in individuals with active ulcer disease or recent GI bleeding. - Check for hypersensitivity: discontinue if rash, swelling, or breathing difficulty occurs. - Monitor concomitant anticoagulant therapy: adjust dosing as needed. - Store below 25°C: keep in the original container, protect from moisture and heat.

Ibuprofen can alter the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Lithium: ibuprofen may raise serum lithium levels, risking toxicity. - Methotrexate: reduced renal clearance can lead to toxicity.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): additive bleeding risk. - Diuretics and ACE inhibitors: may diminish antihypertensive effect and affect renal function. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal and renal adverse events.